Researchers have developed an ultra fast sensor that binds to glutamate. The sensor, dubbed iGluu, is being made available to other researchers to further their neuroscience studies.
Researchers describe how early life exposure to air pollution produces significant brain changes, including enlargement of the part of the brain seen in humans with autism and schizophrenia.
Researchers have uncovered a mechanism in the BNST that senses the negative effects of alcohol and modulates the urge to drink. The study reports that when this mechanism doesn't function correctly, we lose the ability to recognize that we have had enough to drink.
Researchers have discovered a previously unknown mechanism that allows neural networks to protect against the spread of secondary brain damage as seen in TBI and ischemic stroke.
Familial hemiplegic migraine type 2 (FHM2) causes a malfunction of astrocytes in the cingulate cortex. Manipulating astrocytes in the cingulate cortex reversed the disfunction, preventing an increase in migraine-like symptoms in mice carrying the FHM2 defect.
Researchers upend a long-held view about the basic functioning of a key receptor molecule involved in signaling between neurons. The study describes how a compound linked to Alzheimer's disease impacts NMDA receptors and weakens synaptic connections between brain cells.
Researchers measure changes in brain metabolism during tDCS.
A metabolite created as the body breaks down ketamine could hold the key to understanding its antidepressant action, a new study reports.
A new study reports that a genetically specific cluster of hypothalamic cells is wired to the olfactory system and responds only when a male mouse enters another male's cage.
A new study looks at some of the underlying causes of fragile X syndrome and offers suggestions for new treatment targets.
Hangxiety, the feeling of waking up with anxiety the morning after heavy drinking, is a common symptom associated with a hangover. Researchers explain how a heavy night's drinking alters neurochemistry, leaving some of us prone to waking with anxiety.
Researchers have developed an experimental drug, NitroMemantine, to boost brain synapses lost in Alzheimer's disease. The drug stops the destructive cascade of brain changes which destroy connections between neurons that leads to memory loss and cognitive decline.
